NIVF — NewGenIvf Cashflow Statement
0.000.00%
Last trade - 00:00- $2.56m
- $4.14m
Annual cashflow statement for NewGenIvf, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.002 | 0.501 | -0.691 |
| Non-Cash Items | — | -1 | -1.83 |
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.002 | -0.023 | 1.66 |
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | 0 | -0.527 | -0.857 |
| Other Investing Cash Flow Items | — | -69.7 | 51.3 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Cash from Investing Activities | — | -69.7 | 51.3 |
| Financing Cash Flow Items | — | -1.66 | — |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | — | 70.3 | -50.4 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0 | 0.055 | -0.013 |